🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our paper described the longitudinal profile of blood levels of HBV pregenomic RNA in CHB 🦠patients treated with long term NUC 💊now in press CLINICAL AND MOLECULAR HEPATOLOGY e-cmh.org/m/journal/view… Clinical parameters eg age, gender, PAGE-B score and HBeAg can influence pgRNA levels #mfyuen

Our last but not least paper about Covid published at BMJ Public Health - re-infection posed greater risk for hospitalization and mortality compared with first-time infection. Prevention is the still the key ⁦CSMPR_HKU⁩ ⁦Vincent Yan⁩ bmjpublichealth.bmj.com/content/3/1/e0…

Our recent research letter found increasing use of biosimilars in Hong Kong in the last 12 years; while oral tsDMARDs remain the highest retention among patients with rheumatoid arthritis. Great team work from colleagues PhD and MBBS students at HKUMed. onlinelibrary.wiley.com/doi/10.1111/17…

Delighted to share this new paper led by my PhD student Claire Cuiling WEI, investigating rates and rate ratio of multimorbidity incidence after SARS- or influenza-related admissions. Findings now available in npj Journals Prim Care Respir Med by PCRS nature.com/articles/s4153…

Great experience to have a presentation in the APASL-AASLD workshop!! Huge thanks for all the support from the team🙌🏼 loeymak Rex Wan-Hin Hui Carlos KH Wong HKU Medicine AASLD APASL News #APASL2025

Our latest work observed comparable survival benefit but significant lower health resource utilization associated with novel hormonal agents when comparing to docetaxel for the management of prostate cancer. Published at ⁦iScience journal⁩ Cell Press. sciencedirect.com/science/articl…

Our study used cohort and case-crossover design to investigate the risk of gastrointestinal bleeding associated with combined use of oral anticoagulants and proton pump inhibitors using UK and HK data. Findings published in npj Journals nature.com/articles/s4432…

Our Managing Director Joseph Wu and his team from Laboratory of Data Discovery for Health, HKU Medicine & London School of Hygiene & Tropical Medicine unveil the world’s first AI model to classify both stage & risk category of thyroid cancer, with >90% accuracy, reducing preparation time for clinicians by ~50%.

Country Income, Gini Index, Disease Burden and Universal Health Coverage, which one you would expect as the driving factor for the access of WHO essential cancer medicine? Read our fresh online paper on Lancet Oncology.sciencedirect.com/science/articl… HKU Medicine HKU Pharmacy CSMPR_HKU

Our study, the largest conducted to date examining various classes of antihypertensive drugs and dementia risk. We found a lower risk of all-cause dementia with ARBs compared to ACE inhibitors. Hong Kong, UK, Sweden, and Australia data included. doi.org/10.1093/ageing…

Letter written with Dr Angel Wong on bias in a study of PCSK9 inhibitors. Read it in European Heart Journal - Cardiovascular Pharmacotherapy academic.oup.com/ehjcvp/advance… HKU Medicine @hkupharm @csmpr_hkupharm #epidemiology #lipids #pharmacotherapy #cardiology

An other multinational cohort study from our team published this week: trends in survival following dementia diagnosis. ⁦Hao Luo⁩ ⁦Celine Chui HKU⁩ nature.com/articles/s4385…

Our latest multinational study on trends in survival after #Dementia diagnosis has just been published with Springer Nature in Communications Medicine Read here: rdcu.be/eocfU Prof Ian Wong Celine Chui HKU Kenneth Man Martin Knapp Gloria Wong

Register now for the Newcomer Track for the 17th Asian Conference on Pharmacoepidemiology (#ACPE2025) from 21-23 November. Present original research with expert mentorship, receive feedback and network with international leaders. Register by 13 June: hkumed.hk/af8e9e

Our latest longitudinal study on trends in #benzodiazepines and #Z-drug prescribing in Hong Kong has just been published with Elsevier in The Lancet Reg Health-West Pacific. We found increasing trends from 2014 to 2023, with a notable increase in young adults. Esther Chan @ CSMPR HKU

Read the full paper here: sciencedirect.com/science/articl…

Thanks a lot for the professional editing from the Lancet Group. Our podcast about biologics access and recent policy development in Asia Pacific is now on air from the Lancet Rheumatology and the Lancet Regional Health Western Pacific. buzzsprout.com/1907323/episod…

For elderly Asia patients with acute myeloid leukaemia, venetoclax combination with hypomethylating agents showed superior overall survival and less transfusion needs than hypomethylating agents alone, especially the >=75 years group. CSMPR_HKU journals.sagepub.com/doi/10.1177/20…

Our multinational network cohort study shows that extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the subside in risk for most complications over the medium- and long-term. journals.sagepub.com/doi/10.1177/01…

🔬Recent #multinational study involving 22.4M individuals from 🇺🇸🇬🇧🇫🇷🇮🇹🇩🇪 showed extensive multi-organ involvement of post-COVID-19 condition over the short-term and the subside in risk for most complications over time📊 journals.sagepub.com/doi/10.1177/01… #COVID19 #LongCovid #PublicHealth